» Articles » PMID: 30619096

Obesity, Male Reproductive Function and Bariatric Surgery

Overview
Specialty Endocrinology
Date 2019 Jan 9
PMID 30619096
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Overweight and obesity are associated with several chronic complications, such as type 2 diabetes, arterial hypertension and atherosclerotic cardiovascular diseases, with relevant consequences for patients and public health systems. Reproductive function abnormalities, such as obesity-related secondary hypogonadism, erectile dysfunction and infertility, represent other abnormalities negatively affecting the quality of life of men suffering from obesity but, despite their high prevalence, these are often understated because of a general lack of awareness in clinical practice. Obesity and gonadal function are closely related, with obesity being associated with hypogonadism that is reversed by body weight reduction thus ameliorating reproductive and sexual health. Clinical studies specifically evaluating the impact of non-surgical weight loss on testosterone levels sometimes showed conflicting results, whereas extensive literature has demonstrated that weight loss after bariatric surgery is correlated with an increase in testosterone levels greater than that obtained with only lifestyle interventions, suggesting the role of surgery also for the treatment of hypogonadism in obese male. However, studies concerning the consequences of bariatric surgery on overall reproductive function in the male, including also sexual activity and fertility, are limited and data regarding long-term effects are lacking. Here we present a brief review summarizing the evidence regarding the interplay between obesity and reproductive abnormalities in the obese male, together with the role of bariatric surgery for the treatment of these complications, describing both the positive effects and the limitations of this procedure.

Citing Articles

Prescribing semaglutide for weight loss in non-diabetic, obese patients is associated with an increased risk of erectile dysfunction: a TriNetX database study.

Able C, Liao B, Saffati G, Maremanda A, Applewhite J, Nasrallah A Int J Impot Res. 2024; .

PMID: 38778151 DOI: 10.1038/s41443-024-00895-6.


Mapping the Landscape of Obesity Effects on Male Reproductive Function: A Bibliometric Study.

Wei Y, Liao M, Lu Y, Lei X, Wang J, Luo X Endocr Metab Immune Disord Drug Targets. 2024; 24(13):1546-1557.

PMID: 38299282 PMC: 11475102. DOI: 10.2174/0118715303271117231220072051.


Hormonal Changes in Women Undergoing Bariatric Surgery: A Comparative Study with a Control Group.

Anbara T Dev Reprod. 2023; 27(3):117-126.

PMID: 38074461 PMC: 10703099. DOI: 10.12717/DR.2023.27.3.117.


Non-aromatizable androgens modulate the lipopolysaccharide induced expression of the P2X7 receptor in human adipocytes.

Di Vincenzo A, Granzotto M, Crescenzi M, Vettor R, Rossato M Front Pharmacol. 2023; 14:1251035.

PMID: 37936906 PMC: 10627236. DOI: 10.3389/fphar.2023.1251035.


The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice.

Hackett G, Kirby M, Rees R, Jones T, Muneer A, Livingston M World J Mens Health. 2023; 41(3):508-537.

PMID: 36876744 PMC: 10307648. DOI: 10.5534/wjmh.221027.


References
1.
Boonchaya-Anant P, Laichuthai N, Suwannasrisuk P, Houngngam N, Udomsawaengsup S, Snabboon T . Changes in Testosterone Levels and Sex Hormone-Binding Globulin Levels in Extremely Obese Men after Bariatric Surgery. Int J Endocrinol. 2016; 2016:1416503. PMC: 5048048. DOI: 10.1155/2016/1416503. View

2.
Sermondade N, Massin N, Boitrelle F, Pfeffer J, Eustache F, Sifer C . Sperm parameters and male fertility after bariatric surgery: three case series. Reprod Biomed Online. 2011; 24(2):206-10. DOI: 10.1016/j.rbmo.2011.10.014. View

3.
Dong J, Zhang Y, Qin L . Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011; 58(13):1378-85. DOI: 10.1016/j.jacc.2011.06.024. View

4.
De Lorenzo A, Noce A, Moriconi E, Rampello T, Marrone G, Di Daniele N . MOSH Syndrome (Male Obesity Secondary Hypogonadism): Clinical Assessment and Possible Therapeutic Approaches. Nutrients. 2018; 10(4). PMC: 5946259. DOI: 10.3390/nu10040474. View

5.
Sermondade N, Faure C, Fezeu L, Shayeb A, Bonde J, Jensen T . BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis. Hum Reprod Update. 2012; 19(3):221-31. PMC: 3621293. DOI: 10.1093/humupd/dms050. View